Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
  1. 3 Insider Initial Statement of Ownership
  2. 4 Grant or award Director acquired 23,923 shares (grant or award)
  3. 4 Open-market sale Chief Operating Officer sold 2,804 shares at $13.78 ($38,630)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award E.V.P., General Counsel acquired 6,541 shares (grant or award)
  6. 4 Grant or award President, MGL acquired 7,646 shares (grant or award)
  7. 4 Grant or award President Assurex Health Inc. acquired 7,467 shares (grant or award)
  8. 4 Grant or award Chief Scientific Officer acquired 10,068 shares (grant or award)
  9. 4 Grant or award President, MWH acquired 11,525 shares (grant or award)
  10. 4 Grant or award Chief Financial Officer acquired 13,787 shares (grant or award)
  11. 4 Grant or award President and CEO acquired 298,954 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Grant or award Director acquired 25,041 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 5 Insider Annual Insider Trading Report
  16. 4 Grant or award Director acquired 20,562 shares (grant or award)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Grant or award Chief Financial Officer acquired 100,000 shares (grant or award)
  19. 4 Open-market sale President, MGL sold 4,354 shares at $19.73 ($85,915)
  20. 4 Open-market sale President, MWH sold 7,273 shares at $30.00 ($218,190)

Page 22 of 65 · 1,294 filings